Trial intelligence / Profile preview

Permethrin Cream 5% Equivalence in Scabies

NCT03178942Phase 3Completed

Sponsor
Encube Ethicals
Start
Jun 2017
Primary completion
Nov 2017
Modality
Allosteric Modulators
Countries
3
01

Overview

Phase 3, randomised, double-blind trial of permethrin in scabies (2 arms), sponsored by Encube Ethicals. Primary endpoint: Therapeutic Cure (Parasitological Cure Plus Clinical Cure) at Day 28. Started Jun 2017; status: completed.

02

Drugs

permethrin
03

Conditions

scabies

Beyond the preview

Go deeper on NCT03178942.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03178942.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call